Publication | Closed Access

Synergistic co-loading of vincristine improved chemotherapeutic potential of pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer

Drug TargetingChemotherapeutic PotentialPolymer-drug ConjugateMedicinePharmacologyLiposomal DoxorubicinTumor TargetingAnti-cancer AgentSynergistic Co-loadingCancer TreatmentOncologyRadiation OncologyDrug Discovery